LONN:SWX
Lonza Group AG
CHF 499.30
arrow_upward
+0.87%(+4.30) 1D
Jun 16, 2:53:54 PM GMT+2 · CHF
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for LONN...
Open
CHF 498.20
High
CHF 502.80
Low
CHF 494.70
Mkt. cap
35.08B
Avg. vol.
151.89K
Volume
50.69K
Dividend
1.00%
Quarterly dividend
CHF 1.25
Ex-dividend date
May 12, 2026
P/E ratio
38.47
52-wk high
CHF 594.80
52-wk low
CHF 454.60
EPS
CHF 12.98
Shares outstanding
70.23M
No. of employees
20K
Open
CHF 498.20
High
CHF 502.80
Low
CHF 494.70
Mkt. cap
35.08B
Avg. vol.
151.89K
Volume
50.69K
Dividend
1.00%
Quarterly dividend
CHF 1.25
Ex-dividend date
May 12, 2026
P/E ratio
38.47
52-wk high
CHF 594.80
52-wk low
CHF 454.60
EPS
CHF 12.98
Shares outstanding
70.23M
No. of employees
20K
Analyst outlook
Analyst Ratings
Based on 7 analysts giving stock ratings to LONN in the past 3 months
Strong Buy
Buy
7
Hold
0
Sell
0
12 month forecast
Based on 7 Wall Street analysts offering 12 month price targets for LONN in the last 3 months.
Highest
Current CHF 499.30
CHF 762.00 (+52.61%)
Average
CHF 664.00 (+32.99%)
Lowest
CHF 590.00 (+18.17%)
News stories
From sources across the web
Simply Wall Street
·
11 hours ago
Lonza Group (SWX:LONN) Stock After New ADC Partnerships With Antharis And Stipple Bio
Profile
Lonza Group AG is a Swiss multinational manufacturing company for the pharmaceutical, biotechnology and nutrition sectors, headquartered in Basel, with major facilities in Europe, North America and South Asia. Lonza was established under that name in the late 19th-century in Switzerland. The company provides product development services to the pharmaceutical and biologic industries, including custom manufacturing of biopharmaceuticals and detection systems and services for the bioscience sector. Wikipedia
About Lonza Group AG
CEOWolfgang Wienand
Employees20K
Founded1897
HeadquartersBasel, Basel City, Switzerland
SectorHealth care
Websitelonza.com
AI content may include mistakes. Learn more